China could become one of the first countries globally to approve a drug entirely designed by artificial intelligence, signalling a major shift in how new medicines are discovered and developed. Pharmaceutical executives say advances in AI and human genetics are accelerating China’s transition
A major partnership between China’s SciNeuro Pharmaceuticals and Swiss drugmaker Novartis has raised renewed hopes for progress in the fight against Alzheimer’s disease, a condition that affects an estimated 55 million people worldwide and poses a growing burden on global health systems and
China’s booming pet economy is entering an unexpected new phase as rising concern over overweight cats pushes pharmaceutical firms to explore weight loss treatments designed specifically for felines. What began as a social media obsession with adorably pudgy pets is now prompting serious
The United States and the United Kingdom have reached a new agreement that eliminates tariffs on a wide range of pharmaceutical products and medical technologies, a move expected to increase medicine spending within Britain’s National Health Service and provide fresh momentum for the
